CN Patent

CN112218632A — 用ag10治疗ttr淀粉样变性的方法

Assigned to Eidos Therapeutics Inc · Expires 2021-01-12 · 5y expired

What this patent protects

本文描述了用于治疗受试者的转甲状腺素蛋白(TTR)淀粉样变性的方法。所述方法包括在治疗受试者中具有很大功效并且在受试者中良好耐受的特定给药方案。

USPTO Abstract

本文描述了用于治疗受试者的转甲状腺素蛋白(TTR)淀粉样变性的方法。所述方法包括在治疗受试者中具有很大功效并且在受试者中良好耐受的特定给药方案。

Drugs covered by this patent

acoramidis-hydrochloride (ACORAMIDIS HYDROCHLORIDE)

Patent Metadata

Patent number: CN112218632A
Jurisdiction: CN
Classification: —
Expires: 2021-01-12
Drug substance claim: No
Drug product claim: No
Assignee: Eidos Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.